蛋白激酶C和JNK在溶血磷脂酸诱导人肺成纤维细胞MCP-1表达中的作用

doi:10.3969/j.issn.1004-616x.2017.01.006

癌变·畸变·突变 ›› 2017, Vol. 29 ›› Issue (1): 31-36.doi: 10.3969/j.issn.1004-616x.2017.01.006

蛋白激酶C和JNK在溶血磷脂酸诱导人肺成纤维细胞MCP-1表达中的作用

尹齐^1,2,3, 许铭炎², 傅玉才³, 邓小玲¹

1. 厦门大学医学院基础医学部, 福建厦门 361102;
2. 厦门医学院附属口腔医院, 福建厦门 361003;
3. 汕头大学医学院细胞衰老实验室, 广东汕头 515041

收稿日期:2016-04-07 修回日期:2016-11-29 出版日期:2017-01-31 发布日期:2017-01-31
通讯作者: 邓小玲,E-mail:xiaolingdeng@xmu.edu.cn E-mail:xiaolingdeng@xmu.edu.cn
作者简介:尹齐,E-mail:753263430@qq.com;许铭炎,E-mail:myxu@xmu.edu.cn
基金资助:
国家自然科学基金项目（81370160）；厦门大学中央高校基本业务费专项资金项目（20720160053）；福建省自然科学基金青年项目（2015J05171）；福建省卫生系统中青年骨干人才培养项目（2015-ZQN-ZD-35）；厦门市科技惠民计划项目（3502Z20154072）

Protein kinase C and JN K mediate lysophosphatidic acid-induced monocyte chemo-attractant protein-1 expression in human fetal lung fibroblasts

YIN Qi^1,2,3, XU Mingyan², FU Yucai³, DENG Xiaoling¹

1. Department of Basic Medical Science, Xiamen University Medical College, Xiamen 361102;
2. Affiliated Stomatological Hospital of Xiamen Medical College, Xiamen 361003, Fujian;
3. Laboratory of Cellular Senescence, Shantou University Medical College, Shantou 515041, Guangdong, China

Received:2016-04-07 Revised:2016-11-29 Online:2017-01-31 Published:2017-01-31

摘要/Abstract

摘要：

目的：研究蛋白激酶C（PKC）和c-Jun氨基末端激酶（JNK）在溶血磷脂酸（LPA）诱导人肺成纤维细胞（HLF-1）单核细胞趋化蛋白-1（MCP-1）表达中的作用。方法：培养HLF-1细胞，以不同浓度（0、1、3和10 μmol/L）的LPA处理细胞不同时间（0.5、6、12和24 h）后，ELISA检测细胞培养基上清液中MCP-1的蛋白表达，荧光定量PCR检测MCP-1 mRNA的表达水平。用不同浓度的PKC抑制剂Bisindolylmaleimide I（0、0.1、1和10 μmol/L）或JNK抑制剂SP600125（0、0.1、1和10 μmol/L）预孵育细胞30 min后，用LPA（10 μmol/L）刺激2或6 h后，ELISA方法检测细胞培养基上清液中MCP-1的蛋白表达，荧光定量PCR检测MCP-1 mRNA的表达水平。用PKC抑制剂Bisindolylmaleimide I（1 μmol/L）预孵育30 min，以浓度为10 μmol/L的LPA处理细胞不同时间（0、5、30和60 min）后，Western blot检测c-Jun蛋白磷酸化水平。结果：LPA可诱导HLF-1细胞MCP-1蛋白释放，并呈剂量效应和时间效应关系。LPA的浓度为10 μmol/L时，HLF-1细胞释放MCP-1蛋白的量是对照组的2.4倍（P < 0.05）；细胞在LPA处理24 h后，MCP-1蛋白的释放量较对照组增加约1倍（P < 0.05）。LPA可诱导HLF-1细胞MCP-1 mRNA的表达并呈时间效应，LPA处理2 h后，MCP-1 mRNA表达水平是对照组的5.3倍（P < 0.05）。PKC抑制剂Bisindolylmaleimide I和JNK抑制剂SP600125均可显著抑制LPA诱导的HLF-1细胞MCP-1 mRNA表达及MCP-1蛋白释放。Bisindolylmaleimide I的浓度为1 μmol/L时可阻断LPA诱导的HLF-1细胞MCP-1蛋白释放量的60%（P < 0.05），浓度为3 μmol/L时对MCP-1 mRNA表达有明显抑制效果，抑制率达40%（P < 0.05）；而SP600125的浓度为1 μmol/L时可阻断LPA诱导的HLF-1细胞MCP-1蛋白释放量的78%（P < 0.05），对MCP-1 mRNA表达有明显抑制效果，抑制率达87%（P < 0.05）。10 μmol/L的LPA可显著诱导HLF-1细胞c-Jun磷酸化，同时PKC抑制剂Bisindolylmaleimide I（1 μmol/L）可显著抑制LPA（10 μmol/L）诱导的HLF-1细胞c-Jun磷酸化。结论：PKC与JNK通路均参与LPA诱导HLF-1细胞MCP-1的表达。

关键词: 溶血磷脂酸, 蛋白激酶C, c-Jun氨基端激酶, 单核细胞趋化因子-1, 人肺成纤维化细胞

Abstract:

OBJECTIVE: To investigate the role of protein kinase C (PKC) and c-Jun N-terminal kinase (JNK) in modulating lysophosphatidic acid (LPA)-induced monocyte chemo-attractant protein-1 (MCP-1) expression in human fetal lung fibroblasts (HLF-1). METHODS: Cultured human lung fibroblasts (HLF-1) were incubated with LPA(0,1,3 and 10 μmol/L) for 0.5,6,12 and 24 h. ELISA was used to detect MCP-1 protein levels in the supernatants,and quantitative real-time PCR (qPCR) for MCP-1 mRNA levels in the cell lysate. In addition,cells were pre-incubated with PKC inhibitor bisindolylmaleimide I (0,0.1,1 and 10 μmol/L) or JNK inhibitor SP600125 (0,0.1,1 and 10 μmol/L) for 30 min,and then treated with LPA (10 μmol/L) for 2 or 6 h,and ELISA and qPCR assays were conducted. Cells were also pre-incubated with PKC inhibitor bisindolylmaleimide I (1 μmol/L) for 30 min,and then treated with LPA (10 μmol/L) for 30 min. C-Jun N-terminal phosphorylation levels in the cell lysate were measured by Western blot. RESULTS: LPA stimulated MCP-1 protein expression in dose- and time-dependent manners. The MCP-1 protein production in the LPA (10 μmol/L) treated group was 2.4 times higher than that in the untreated group (P < 0.01). MCP-1 protein production in the LPA (10 μmol/L) treated group for 24 h was 1 time higher than that in the untreated group (P < 0.01). LPA stimulated MCP-1 mRNA expression in a time-dependent manner. The MCP-1 mRNA expression in the LPA (10 μmol/L) treated group for 2 h was 5.3 times higher than that in the untreated group (P < 0.01). PKC inhibitors bisindolylmaleimide I and JNK SP600125 clearly inhibited LPA-induced MCP-l mRNA and protein expressions. The LPA (10 μmol/L)-induced MCP-1 protein production was reduced by 60% with bisindolylmaleimide I(1 μmol/L) compared with that in the control group (P < 0.05). With 3 μmol/L of bisindolylmaleimide I,the induced MCP-1 mRNA expression was reduced by 40% (P < 0.05). The LPA (10 μmol/L)-induced MCP-1 protein production was reduced by 78% with SP600125 (1 μmol/L) (P < 0.05). The 10 μmol/L LPA-induced MCP-1 mRNA expression was reduced by 40% with SP600125 (1 μmol/L) (P < 0.05). The activity of JNK was enhanced by LPA in HLF-1 while PKC inhibitors bisindolylmaleimide I (1 μmol/L) suppressed the activity of JNK which was induced by LPA(10 μmol/L). CONCLUSION: PKC and JNK mediated LPA-induced MCP-1 expression in HLF-1.

Key words: lysophosphatidic acid, protein kinase C, c-Jun N-terminal kinase, monocyte chemo-attractant protein-1, human lung fibroblasts

中图分类号:

R329.2

尹齐, 许铭炎, 傅玉才, 邓小玲. 蛋白激酶C和JNK在溶血磷脂酸诱导人肺成纤维细胞MCP-1表达中的作用[J]. 癌变·畸变·突变, 2017, 29(1): 31-36.

YIN Qi, XU Mingyan, FU Yucai, DENG Xiaoling. Protein kinase C and JN K mediate lysophosphatidic acid-induced monocyte chemo-attractant protein-1 expression in human fetal lung fibroblasts[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(1): 31-36.

参考文献

[1] GHARAEE-KERMANI M,DENHOLM E M,PHAN S H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors[J]. J Biol Chem,1996,271(30):17779-17784.

[2] TANG N,ZHAO Y,FENG R,et al. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts[J]. J Cell Mol Med,2014,18(1):156-169.

[3] CONG C,MAO L,ZHANG Y,et al. Regulation of silicosis formation by lysophosphatidic acid and its receptors[J]. Exp Lung Res,2014,40(7):317-326.

[4] ZHAO C,HUI W,FERNANDES M,et al. Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes[J]. Biochem Pharmacol,2014,90(1):62-72.

[5] STODDARD N C,CHUN J. Promising pharmacological directions in the world of lysophosphatidic acid signaling[J]. Biomol Ther (Seoul),2015,23(1):1-11.

[6] KONTNY E,ZIOLKOWSKA M,MASLINSKI W. Production of pro-inflammatory cytokines in human monocytes:not a cascade but the dependence on protein kinase C pathway[J]. Immunol Lett,1999,67(3):263-267.

[7] WANG C Y,DENG Y T,HUANG S Y,et al. Epigallocatechin-3-gallate inhibits lysophosphatidic acid-stimulated connective tissue growth factor via JNK and Smad3 suppression in human gingival fibroblasts[J]. J Formos Med Assoc,2014,112(1):50-55.

[8] JEON E S,KIM J H,RYU H,et al. Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-beta1-dependent pathway[J]. Cell Signal, 2012,24(6):1241-1250.

[9] 袁超,许铭炎,陈耿臻,等. PKC介导凝血酶诱导人肺成纤维细胞单核细胞趋化蛋白-1的表达[J]. 南方医科大学学报,2012,32(9):1250-1254.

[10] DENG X,XU M,YUAN C,et al. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-kappaB and activator protein-1[J]. Int J Biochem Cell Biol,2013,45(7):1366-1376.

[11] BUDD D C,QIAN Y. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis[J]. Future Med Chem,2013,5(16):1935-1952.

[12] STORTELERS C,KERKHOVEN R,MOOLENAAR W H,et al. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling[J]. BMC Genomics,2008, 9(387):1-15.

[13] GAN X,WANG J,WANG C,et al. PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Gα12[J]. Nat Cell Biol,2012, 14(7):686-696.

[14] ALCORN J F,VANDER VELDEN J,BROWN A L,et al. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis[J]. Am J Respir Cell Mol Biol,2009,40(4):422-432.

[15] YU J,OK S H,KIM W H,et al. Dexmedetomidine-induced contraction in the isolated endothelium-denuded rat aorta involves PKC-delta-mediated JNK phosphorylation[J]. Int J Med Sci,2015,12(9):727-736.

[16] KONTNY E,ZIOLKOWSKA M,MASLINSKI W. Production of pro-inflammatory cytokines in human monocytes:not a cascade but the dependence on protein kinase C pathway[J]. Immunol Lett,1999,67(3):263-267.

[17] MESSOUSSI A,FENEYROLLES C,BROS A,et al. Recent progress in the design,study,and development of c-Jun N-terminal kinase inhibitors as anticancer agents[J]. Chem Biol,2014,21(11):1433.

蛋白激酶C和JNK在溶血磷脂酸诱导人肺成纤维细胞MCP-1表达中的作用

Protein kinase C and JN K mediate lysophosphatidic acid-induced monocyte chemo-attractant protein-1 expression in human fetal lung fibroblasts

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	周小琼，邓小玲，傅玉才，许铭炎. TGF-β及EGF信号对溶血磷脂酸诱导口腔鳞癌细胞增殖的影响[J]. 癌变·畸变·突变, 2014, 26(1): 6-9.
[2]	王锦芝,蔡聪艺,张艳美,石刚刚. 蛋白激酶Cε在缺氧复氧心肌细胞中的调控作用[J]. , 2012, 24(3): 217-221.
[3]	周丽;李杰;刘建军;徐新云;杨淋清. 镉对NRK肾细胞PKCα表达的影响及PKC抑制剂BisⅠ的生物学作用[J]. , 2010, 22(3): 191-195.
[4]	苏湘鄂;聂晓云. 不同分化期乳腺癌细胞PKCs的表达及其对TNFα的敏感性[J]. , 2006, 18(4): 281-283.
[5]	任　重　马　明　宗志宏. 喉癌与蛋白激酶C 及其抑制物的关系[J]. , 1998, 10(3): 160-163.